Sanara MedTech Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Sanara MedTech Inc. (SMTI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-9.91-4.44-7.94-7.92-4.450.00
Depreciation & Amortization4.923.682.370.600.290.00
Deferred Income Tax0.000.00-5.840.000.000.00
Stock Based Compensation4.443.442.702.671.400.00
Change in Working Capital-0.91-2.250.52-1.18-2.200.00
Change in Accounts Receivable-4.54-1.73-2.27-0.77-0.960.00
Change in Inventory1.44-1.55-0.52-1.15-0.720.00
Change in Accounts Payable-0.470.58-0.420.100.090.00
Change in Other Working Capital2.66-2.601.090.650.420.00
Other Operating Activities1.440.011.090.352.890.00
Net Cash from Operating Activities-0.02-3.25-5.55-4.81-4.03-2.17
Investing Activities
Capital Expenditures-0.230.27-0.75-0.171.640.00
Acquisitions0.00-9.94-2.52-4.53-1.100.00
Purchases of Investments-5.300.00-0.25-4.53-1.100.00
Sales/Maturities of Investments0.000.00-0.60-0.58-1.100.00
Other Investing Activities-1.100.000.000.000.000.00
Net Cash from Investing Activities-6.61-10.21-3.51-5.28-2.74-1.20
Financing Activities
Debt Repayment19.590.000.00-0.800.000.00
Common Stock Issued0.000.910.0028.940.040.00
Other Financing Activities-2.15-0.82-0.22-0.646.616.61
Net Cash from Financing Activities17.379.64-0.6328.300.626.61
Summary
Net Change in Cash10.73-3.81-9.6918.20-6.166.61
Cash at Beginning of Period5.158.9618.650.466.610.18
Cash at End of Period15.88-3.518.9618.656.616.79
Free Cash Flow-0.25-3.51-6.30-4.99-5.68-2.17
Supplemental Disclosures
Interest Paid1.580.280.000.000.000.00